{
  "meta": {
    "title": "Anti-Cholinergic_Drugs",
    "url": "https://brainandscalpel.vercel.app/anti-cholinergic-drugs-8ce793c4.html",
    "scrapedAt": "2025-11-29T18:33:40.586Z"
  },
  "questions": [
    {
      "id": 3289,
      "choices": [
        {
          "id": 13135,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
        },
        {
          "id": 13136,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
        },
        {
          "id": 13137,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
        },
        {
          "id": 13138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following drugs increases gastrointestinal motility?</span></span></span></p>",
      "unique_key": "Q5455340",
      "question_audio": null,
      "question_video": null,
      "map_id": 35942,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Neostigmine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine increases gastrointestinal motility </strong>by inhibiting <strong>acetylcholinesterase</strong>, the enzyme responsible for <strong>breaking down</strong> <strong>acetylcholine at cholinergic synapses</strong>. This action results in an <strong>increased concentration of acetylcholine</strong> at the neuromuscular junctions within the <strong>gastrointestinal tract,</strong> enhancing<strong> smooth muscle contraction </strong>and thereby <strong>promoting gastrointestinal motility.</strong> <strong>Neostigmine&#39;s </strong>effect on the <strong>gastrointestinal system</strong> is part of its broader pharmacological profile as a<strong> parasympathomimetic agent,</strong> which<strong> stimulates the parasympathetic nervous system</strong> and can be used to treat conditions such as <strong>postoperative abdomina</strong>l <strong>distension and urinary retention.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate:</strong> Glycopyrrolate is an <strong>anticholinergic drug </strong>that <strong>decreases gastrointestinal motility.</strong> It works by blocking <strong>acetylcholine receptors </strong>in the<strong> gastrointestinal tract</strong>, <strong>reducing smooth muscle contractions and secretions</strong>. <strong>Glycopyrrolate </strong>is often used<strong> preoperatively to reduce salivary, tracheobronchial, and pharyngeal secretions</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine:</strong> Atropine is another <strong>anticholinergic drug </strong>that <strong>reduces gastrointestinal motility </strong>by inhibiting the action of <strong>acetylcholine on muscarinic receptors in the gut</strong>. This results in <strong>decreased muscle tone and motility</strong> in the <strong>digestive tract.</strong> Atropine is used in various clinical settings, including <strong>pre-anesthetic medication</strong> to <strong>reduce salivation and increase heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fentanyl:</strong> Fentanyl is a<strong> synthetic opioid analgesic, </strong>which<strong> does not </strong>directly affect<strong> gastrointestinal motility </strong>as<strong> its primary action</strong>. However, <strong>opioids</strong>, in general, are known to <strong>reduce gastrointestinal motility </strong>due to their <strong>inhibitory effects </strong>on the <strong>enteric nervous system</strong>, leading to <strong>constipation </strong>as a common side effect.<strong> Fentanyl&#39;s main </strong>use is for <strong>pain management</strong>, <strong>not for modulating gastrointestinal motility</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine</strong>, a <strong>parasympathomimetic agent</strong>, <strong>increases gastrointestinal motility</strong> by <strong>inhibiting acetylcholinesterase</strong> and <strong>increasing</strong> <strong>acetylcholine levels</strong>. In contrast, <strong>anticholinergic drugs like glycopyrrolate and atropine decrease gastrointestinal motility </strong>by blocking <strong>acetylcholine receptors.</strong> <strong>Fentanyl, an opioid analgesic, </strong>can<strong> indirectly decrease gastrointestinal motility </strong>as a side effect of its<strong> analgesic use. </strong></span></span></p>",
      "correct_choice_id": 13137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3312,
      "choices": [
        {
          "id": 13227,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Organophosphate poisoning</span></span></span></p>"
        },
        {
          "id": 13228,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></span></span></p>"
        },
        {
          "id": 13229,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid poisoning</span></span></span></p>"
        },
        {
          "id": 13230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pontine hemorrhage</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents to emergency with pinpoint pupil, salivation, lacrimation, tremors and red tears. Plasma cholinesterase level was 30% of normal. Most probable Diagnosis is? </span></span></span></p>",
      "unique_key": "Q2304902",
      "question_audio": null,
      "question_video": null,
      "map_id": 35937,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Organophosphate poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of <strong>pinpoint pupils (miosis), excessive salivation, lacrimation, muscle tremors, </strong>and the unusual finding of <strong>red tears</strong>, combined with significantly <strong>reduced plasma cholinesterase levels (30% of normal), </strong>strongly suggests <strong>organophosphate poisoning. </strong>Organophosphates <strong>inhibit acetylcholinesterase, </strong>leading to the <strong>accumulation of acetylcholine at cholinergic synapses and neuromuscular junctions</strong>. This results in <strong>overstimulation of muscarinic and nicotinic receptors</strong>, manifesting as the <strong>muscarinic signs (miosis, salivation, lacrimation) and nicotinic signs (muscle tremors) </strong>observed.<strong> Organophosphates </strong>are commonly used in agriculture as <strong>pesticides</strong>, and <strong>exposure </strong>can occur through <strong>inhalation, ingestion, or skin contact</strong>, which is consistent with the patient being a<strong> farm worker</strong>. The <strong>red tears </strong>could be related to <strong>conjunctival </strong>exposure to the <strong>chemical or a secondary effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dhatura poisoning:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dhatura</strong>, a <strong>plant </strong>containing <strong>anticholinergic tropane alkaloids </strong>(e.g., <strong>atropine, scopolamine</strong>), would cause <strong>anticholinergic syndrome</strong>, characterized by <strong>dry skin and mucous membranes, flushed face, hyperthermia, mydriasis (dilated pupils), and hallucinations. </strong>This is<strong> opposite to the cholinergic signs </strong>seen in the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Opioid poisoning:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid poisoning can cause <strong>pinpoint pupils</strong>, but the predominant symptoms would also include <strong>respiratory depression and decreased level of consciousness</strong>, which are not mentioned in the scenario. <strong>Opioids do not </strong>cause <strong>excessive salivation or lacrimation</strong>, nor do they affect <strong>plasma cholinesterase levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pontine hemorrhage:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While pontine hemorrhage can lead to<strong> pinpoint pupils </strong>due to disruption of the <strong>sympathetic pathways</strong>, it would also typically present with <strong>acute neurological deficits like altered consciousness, paralysis, or other focal neurological signs</strong>, which are not described in this scenario. Additionally,<strong> pontine hemorrhage </strong>would <strong>not explain </strong>the <strong>reduced plasma cholinesterase levels </strong>or the specific combination of symptoms mentioned.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to recognize the <strong>clinical presentation of organophosphate poisoning,</strong> which includes signs of <strong>cholinergic</strong> excess such as <strong>miosis, excessive salivation, lacrimation, and muscle tremors,</strong> along with <strong>reduced plasma cholinesterase levels</strong>. <strong>Understanding the clinical features and laboratory findings </strong>associated with this condition is critical for<strong> prompt diagnosis and treatment</strong>.</span></span></span></p>",
      "correct_choice_id": 13227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3351,
      "choices": [
        {
          "id": 13383,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost </span></span></p>"
        },
        {
          "id": 13384,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></p>"
        },
        {
          "id": 13385,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></p>"
        },
        {
          "id": 13386,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-glaucoma drug that acts by increasing uveoscleral outflow is:</span></span></span></p>",
      "unique_key": "Q1003133",
      "question_audio": null,
      "question_video": null,
      "map_id": 35940,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Latanoprost</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Latanoprost</strong> is an <strong>anti-glaucoma medication</strong> that works by <strong>increasing the uveoscleral outflow of aqueous humor, </strong>which helps to <strong>lower intraocular pressure </strong>in patients with<strong> glaucoma or ocular hypertension.</strong> It is a <strong>prostaglandin analog,</strong> which <strong>distinguishes its</strong> <strong>mechanism of action</strong> from other classes of <strong>glaucoma medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Timolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Timolol is a<strong> beta-blocke</strong>r used in the <strong>treatment of glaucoma,</strong> but it works by <strong>decreasing aqueous</strong> <strong>humor production in the eye,</strong> not by increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dorzolamide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Dorzolamide is a carbonic anhydrase inhibitor</strong> that also<strong> reduces intraocular pressure</strong> by <strong>decreasing aqueous humor production</strong>. It does not act by increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pilocarpine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pilocarpine is a muscarinic agonist</strong> that reduces i<strong>ntraocular pressure by increasing the outflow of</strong> <strong>aqueous humor</strong> through the <strong>trabecular meshwork,</strong> which is different from increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to recognize the<strong> mechanism of action </strong>of different <strong>anti-glaucoma medications</strong>, particularly identifying <strong>latanoprost as</strong> a drug that<strong> reduces intraocular pressure </strong>by <strong>increasing uveoscleral outflow. </strong>Understanding how various <strong>anti-glaucoma </strong>drugs work is essential for selecting appropriate treatment options based on the individual needs and pathophysiology of the patient&#39;s glaucoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of anti-glaucoma drugs</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/99.jpg\" style=\"height:359px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 13383,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3325,
      "choices": [
        {
          "id": 13279,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirenzepine </span></span></span></p>"
        },
        {
          "id": 13280,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tolterodine</span></span></span></p>"
        },
        {
          "id": 13281,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide </span></span></span></p>"
        },
        {
          "id": 13282,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"margin-left:6px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an antimuscarinic drug useful in overactive bladder?</span></span></span></p>",
      "unique_key": "Q3853219",
      "question_audio": null,
      "question_video": null,
      "map_id": 35944,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp; B) Tolterodine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Overactive bladder (Detrusor instability)</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Detrusor instability or overactive bladder </strong>is characterized by <strong>uninhibited, unstable contractions of the detrusor muscle.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since <strong>detrusor contracts</strong> under <strong>parasympathetic influence</strong>, <strong>anticholinergic drugs</strong> are used to <strong>treat overactive bladder.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These agents<strong> lower intravesical pressure</strong>,<strong> increase capacity </strong>and<strong> reduce the frequency of contractions</strong> by <strong>antagonizing</strong> <strong>parasympathetic tone of bladder.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These agents include: -</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">olefenacin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; O</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">xybutynin </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">F: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lavoxate</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">olterodine and <strong>T</strong>rospium</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bla<strong>DAR:</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>DAR</strong>ifenacin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A. Pirenzepine:</strong> Pirenzepine is primarily used as a<strong> selective M1 muscarinic receptor antagonist</strong> in the treatment of <strong>peptic</strong> <strong>ulcers.</strong> It is <strong>not indicated </strong>for the treatment of<strong> overactive bladder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tropicamide:</strong> Tropicamide is a<strong> muscarinic receptor antagonist </strong>used as a <strong>mydriatic agent</strong> to induce <strong>pupillary dilation</strong> for <strong>ophthalmic examinations. </strong>It is <strong>not indicated</strong> for the treatment of <strong>overactive bladder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine:</strong> Atropine is a <strong>non-selective muscarinic receptor antagonist</strong> used for various purposes, including the <strong>treatment of bradycardia, organophosphate poisoning, </strong>and as a<strong> preanesthetic medication</strong>. While it can <strong>reduce detrusor muscle activity</strong>, it is <strong>not </strong>commonly used for the<strong> treatment of overactive bladder</strong> due to its<strong> non-selective nature and potential side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tolterodine,</strong> as an <strong>antimuscarinic agent, </strong>is commonly used in the <strong>treatment of overactive bladder</strong> due to its <strong>ability to reduce urinary frequency, urgency, and urge incontinence </strong>by <strong>blocking muscarinic receptors</strong> in the<strong> bladder. </strong></span></span></p>",
      "correct_choice_id": 13280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3309,
      "choices": [
        {
          "id": 13215,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &alpha;1 and &beta;1</span></span></span></p>"
        },
        {
          "id": 13216,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &alpha;1 and &beta;2</span></span></span></p>"
        },
        {
          "id": 13217,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &beta;1 and &beta;2</span></span></span></p>"
        },
        {
          "id": 13218,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &beta;1 and antagonist at &alpha;1</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing of a drug related to autonomic nervous system was planned. The drug and a placebo were administered in a healthy volunteer? The following effect were seen. What are the likely characteristics of the drug?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121656.jpg\" style=\"height:516px; width:1000px\" /></span></span></span></p>",
      "unique_key": "Q3596102",
      "question_audio": null,
      "question_video": null,
      "map_id": 35935,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Agonist at &beta;1 and &beta;2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> drug shows </strong>characteristics of<strong> increased heart rate (tachycardia) and increased systolic blood pressure</strong>, which are indicative of <strong>&beta;1 agonist action.</strong> The <strong>decrease in diastolic blood pressure </strong>and the<strong> presence of tremors suggest &beta;2 agonist </strong>activity, as <strong>&beta;2 receptors</strong> are responsible for <strong>vasodilation in certain blood vessels </strong>and can cause<strong> tremors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &nbsp;Agonist at &alpha;1 and &beta;1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect </strong>because <strong>&alpha;1 stimulation </strong>would <strong>increase both systolic and diastolic blood pressure,</strong> which is not observed. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Agonist at &alpha;1 and &beta;2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrec</strong>t because <strong>&alpha;1 agonist action</strong> would<strong> not</strong> result in<strong> decreased diastolic blood pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Agonist at &beta;1 and antagonist at &alpha;1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong> Incorrect</strong> because an <strong>&alpha;1 antagonist</strong> would lead to a<strong> decrease in both systolic and diastolic blood pressure, not an increase in systolic pressure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The characteristic effects of<strong> tachycardia and changes in blood pressure,</strong> along with the <strong>presence of tremors</strong>, suggest that the drug has <strong>agonistic activity at &beta;1 and &beta;2 receptors,</strong> making it a likely candidate for a <strong>beta-adrenergic agonist</strong> with <strong>both cardiac and</strong> <strong>peripheral actions.</strong></span></span></p>",
      "correct_choice_id": 13217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3275,
      "choices": [
        {
          "id": 13079,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.5&ndash;1 kg </span></span></span></p>"
        },
        {
          "id": 13080,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1.5&ndash;2.5 kg </span></span></span></p>"
        },
        {
          "id": 13081,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5&ndash;7 kg</span></span></span></p>"
        },
        {
          "id": 13082,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10&ndash;12 kg</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the usual weight of rabbit used in ophthalmological experiments? </span></span></span></p>",
      "unique_key": "Q8789306",
      "question_audio": null,
      "question_video": null,
      "map_id": 35934,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1.5&ndash;2.5 kg</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laboratory animals </strong>used for various experiments include<strong> rat, mice, guinea pig, rabbit and hamster.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Weight of rats</strong> used in these experiments is <em>180-200 g </em>whereas that of <strong>rabbit is 1.5-2.5 Kg.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scientific name of <strong>rabbit is Oryctalagus cuniculus.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The typical <strong>weight for rabbits</strong> used in<strong> ophthalmological experiments</strong> is <strong>1.5 to 2.5 kilograms. </strong></span></span></span></p>",
      "correct_choice_id": 13080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3283,
      "choices": [
        {
          "id": 13111,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a selective alpha 2 receptor agonist</span></span></span></p>"
        },
        {
          "id": 13112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It decreases central sympathetic outflow</span></span></span></p>"
        },
        {
          "id": 13113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It increases the release of renin</span></span></span></p>"
        },
        {
          "id": 13114,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be used for treatment of hypertension. </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is not true about clonidine?</span></span></span></p>",
      "unique_key": "Q4419113",
      "question_audio": null,
      "question_video": null,
      "map_id": 35939,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It increases the release of renin&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clonidine </strong>is a <strong>selective &alpha;2 adrenergic receptor </strong>agonist that d<strong>ecreases sympathetic outflow from the central nervous system</strong>, leading to <strong>decreased blood pressure and heart rate.</strong> It<strong> reduces the release of renin</strong> from the kidneys due to its <strong>inhibitory effect</strong> on <strong>sympathetic activity.</strong> Clonidine<strong> does not increase renin release</strong>; rather, it <strong>decreases</strong> it by lessensing the <strong>stimulation of &beta;1 receptors</strong> in the<strong> juxtaglomerular cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Acts as a <strong>selective &alpha;2 receptor agonist.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Stimulation of alpha 2A receptors</strong> in <strong>brainstem</strong> result in <strong>decrease sympathetic outflow</strong>&mdash;, <strong>fall in BP and bradycardia </strong>(also due to enhanced vagal tone).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used to treat various conditions including<strong> hypertension, menopausal syndrome, and withdrawal syndromes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline </strong>is specific to<strong> &alpha;1, &alpha;2, and &beta;1 receptors </strong>and <strong>does not activate &beta;2 receptors</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clonidine, an &alpha;2 receptor agonist</strong>, <strong>decreases sympathetic outflow </strong>and <strong>renin release</strong>, contrary to increasing it, which is an important consideration in its pharmacological profile and clinical use.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 13113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3288,
      "choices": [
        {
          "id": 13131,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases gastric secretion</span></span></span></p>"
        },
        {
          "id": 13132,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolongs A-V conduction</span></span></span></p>"
        },
        {
          "id": 13133,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases tracheobronchial secretions</span></span></span></p>"
        },
        {
          "id": 13134,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Results in unopposed contraction of radial muscle of iris</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are actions of a muscarinic antagonist except?</span></span></span></p>",
      "unique_key": "Q9592958",
      "question_audio": null,
      "question_video": null,
      "map_id": 35941,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Prolongs A-V conduction </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscarinic antagonists,</strong> such as <strong>atropine</strong>, primarily block the actions of <strong>acetylcholine at muscarinic receptors</strong>, which are part of the <strong>parasympathetic nervous system</strong>. Their effects include <strong>dilation of the pupils, decreased secretion in the airways and stomach</strong>, and <strong>increased heart rate</strong>. However, the specific action on heart conduction is often misunderstood:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolongs A-V conduction&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>incorrect </strong>in the context of <strong>muscarinic antagonists&#39; effects</strong>. These agents typically <strong>shorten A-V conduction </strong>time, <strong>not prolong </strong>it, by blocking the <strong>muscarinic receptors in the heart </strong>that mediate the <strong>vagal tone&#39;s</strong> slowing effect on <strong>heart rate and conduction.</strong> This results in an<strong> increased heart rate (tachycardia) </strong>and can <strong>facilitate faster</strong> <strong>A-V nodal conduction</strong>, opposite to prolongation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Decreases gastric secretion:</strong> <strong>Correct. Muscarinic antagonists reduce gastric acid secretion </strong>by blocking the<strong> muscarinic M3</strong> <strong>receptors</strong> on the gastric parietal cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Decreases tracheobronchial secretions:</strong> <strong>Correct.</strong> These agents<strong> reduce secretions</strong> in the <strong>airway</strong> by <strong>inhibiting muscarinic</strong> <strong>receptors</strong> in the bronchial glands.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Causes unopposed contraction of radial muscle of iris:</strong> <strong>Muscarinic antagonists </strong>cause <strong>pupil dilation (mydriasis)</strong> by blocking the<strong> M3 receptors</strong> on the<strong> sphincter pupillae muscle</strong>. However, the<strong> pupil</strong> is also supplied by the <strong>radial muscle, </strong>which is controlled by <strong>sympathetic innervation.</strong> Therefore, when <strong>M3 receptors are blocked by anticholinergic drugs</strong>, <strong>sphincter pupillae</strong> <strong>cannot contrac</strong>t and there is unopposed<strong> contraction of radial muscles </strong>via<strong> sympathetic system </strong>leading to <strong>dilation of pupil</strong>. This is known as <strong>passive mydriasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Muscarinic antagonists shorten A-V conduction </strong>time rather than prolonging it, which reflects their overall effect of<strong> reducing parasympathetic activity on the heart</strong>.</span></span></p>",
      "correct_choice_id": 13132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3294,
      "choices": [
        {
          "id": 13155,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 hours</span></span></span></p>"
        },
        {
          "id": 13156,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12 hours</span></span></span></p>"
        },
        {
          "id": 13157,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 day</span></span></span></p>"
        },
        {
          "id": 13158,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-2 weeks</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cycloplegic action of atropine lasts upto? </span></span></span></p>",
      "unique_key": "Q5351403",
      "question_audio": null,
      "question_video": null,
      "map_id": 35945,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1-2 weeks </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine </strong>is a <strong>potent muscarinic antagonist </strong>with a broad range of pharmacological effects, including <strong>cycloplegia</strong>, which is <strong>paralysis </strong>of the <strong>ciliary muscle of the eye</strong>, resulting in a <strong>loss of accommodation, and mydriasis</strong>, which is <strong>dilation of the pupil</strong>. The <strong>cycloplegic action of atropine </strong>is particularly <strong>long-lasting</strong>. When <strong>administered in the eye</strong>, <strong>atropine </strong>can cause <strong>cycloplegia </strong>that lasts up to<strong> 1-2 weeks</strong>. This <strong>extended duration </strong>is <strong>due to its strong affinity </strong>for<strong> muscarinic receptors </strong>and its <strong>relatively slow rate of dissociation </strong>from these<strong> receptors</strong>, leading to prolonged effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The <strong>educational objective </strong>is to recognize the <strong>duration of the cycloplegic effect </strong>of different drugs used in <strong>ophthalmic applications</strong>. Understanding the<strong> long-lasting action of atropine </strong>is crucial for <strong>healthcare </strong>providers in managing conditions requiring<strong> cycloplegia, such as uveitis</strong>, where <strong>prolonged pupil dilation and paralysis of accommodation are beneficial</strong>. </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120249.jpg\" style=\"height:263px; width:1000px\" /></span></span></p>",
      "correct_choice_id": 13158,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3300,
      "choices": [
        {
          "id": 13179,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-1 agonist action leading to peripheral vasoconstriction</span></span></span></p>"
        },
        {
          "id": 13180,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in renal perfusion due to agonist action on D1 receptors</span></span></span></p>"
        },
        {
          "id": 13181,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Releases noradrenaline and causes positive inotropic effect</span></span></span></p>"
        },
        {
          "id": 13182,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct action on heart via beta-1 receptors</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male patient with a history of hypertension and diabetes is brought to the emergency department in a state of acute shock. He is hypotensive with a blood pressure of 80/50 mmHg, tachycardic with a heart rate of 110 bpm, and his skin is cold and clammy. The medical team is considering the use of dopamine as part of his management. Among the following properties of dopamine. Which of them is not helpful in acute shock?</span></span></span></p>",
      "unique_key": "Q8490319",
      "question_audio": null,
      "question_video": null,
      "map_id": 35932,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Increase in renal perfusion due to agonist action on D1 receptors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in renal perfusion due to agonist action on D1 receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Dopamine&#39;s action</strong> on <strong>D1 receptors</strong> in the<strong> renal vasculature</strong> can <strong>increase renal blood flow.</strong> This is potentially beneficial in maintaining <strong>renal function</strong> and<strong> preventing acute kidney injury</strong>, a common <strong>complication of shock</strong>. However, in the context of <strong>acute shock management</strong>, where the primary goal is to<strong> stabilize hemodynamic,</strong> this <strong>renal perfusion effect </strong>is <strong>not</strong> the primary therapeutic aim but can be considered a beneficial effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Alpha-1 agonist action leading to peripheral vasoconstriction:</strong>&nbsp;<strong>In shock,</strong> especially <strong>distributive shock (e.g., septic shock),</strong> <strong>peripheral vasodilation</strong> is a common issue <strong>leading to hypotension. T</strong>he <strong>alpha-1 agonist</strong> action of <strong>dopamine</strong> causes <strong>peripheral</strong> <strong>vasoconstriction</strong>, which can help <strong>increase systemic vascular resistance</strong> and thereby <strong>raise blood pressure</strong>. This action is beneficial in <strong>acute shock management.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Releases noradrenaline and causes positive inotropic effect:</strong>&nbsp;Dopamine causes the release of <strong>noradrenaline</strong> <strong>(norepinephrine) </strong>and exerts a<strong> positive inotropic effect </strong>(<strong>increasing cardiac contractility</strong>). The release of noradrenaline can occur by three mechanisms:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">Dopamine is a key intermediate in the biosynthesis of norepinephrine. Therefore, increased availability of dopamine leads to increased synthesis of norepinephrine.</span></li>\r\n\t<li><span style=\"font-size:16px\">Beta 1 receptors are present presynpatically in sympathetic nerve terminals. Stimulation of these receptors by dopamine&nbsp;can cause the release of stored norepinephrine.</span></li>\r\n\t<li><span style=\"font-size:16px\">Dopamine can also cause&nbsp;<strong>indirect release of norepinephrine</strong>&nbsp;by increasing intracellular calcium in sympathetic nerve terminals. This increase in calcium facilitates the exocytosis of norepinephrine-containing vesicles, leading to the release of norepinephrine into the synaptic cleft.</span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This action is <strong>highly beneficial in shock</strong>, particularly in<strong> cardiogenic shock, </strong>where the <strong>heart&#39;s ability</strong> to <strong>pump blood is compromised. </strong>The <strong>positive inotropic effect </strong>helps improve<strong> cardiac output.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Direct action on heart via beta-1 receptors:&nbsp;Dopamine&#39;s</strong> direct action on <strong>beta-1 receptors</strong> in the heart <strong>increases heart</strong> <strong>rate and contractility.</strong> In <strong>acute shock</strong>, especially in cases where <strong>cardiac output is low,</strong> this action can be beneficial in <strong>improving</strong> <strong>hemodynamics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on this analysis, the option that is &quot;not helpful&quot; in the acute management of shock is option b - <strong>&quot;Increase in renal perfusion</strong> due to <strong>agonist action on D1 receptors</strong>&quot;. While it is beneficial for <strong>renal protection,</strong> it is <strong>not</strong> directly involved in the<strong> immediate</strong> <strong>hemodynamic stabiliatzion</strong> which is the primary goal.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of<strong> acute shock, </strong>the priority is to <strong>stabilize hemodynamics</strong>, which includes<strong> improving cardiac output</strong> and <strong>increasing systemic vascular resistance.</strong> <strong>Dopamine&#39;s alpha-1 agonist </strong>action, which causes <strong>peripheral vasoconstriction,</strong> and its<strong> beta-1 </strong>effects, which <strong>increase cardiac contractility and heart rate</strong>, are the key beneficial properties in this context. The effect of <strong>dopamine</strong> <strong>on D1 receptors</strong> to <strong>increase renal perfusion</strong>, while potentially <strong>protective for kidney function,</strong> is<strong> not</strong> the primary focus during the initial management of<strong> acute shock.</strong></span></span></p>",
      "correct_choice_id": 13180,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3310,
      "choices": [
        {
          "id": 13219,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopaminergic</span></span></span></p>"
        },
        {
          "id": 13220,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinergic</span></span></span></p>"
        },
        {
          "id": 13221,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenergic</span></span></span></p>"
        },
        {
          "id": 13222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonergic</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are receptors are present on the ganglion?</span></span></span></p>",
      "unique_key": "Q4179005",
      "question_audio": null,
      "question_video": null,
      "map_id": 35936,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cholinergic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>autonomic ganglia</strong>, where <strong>preganglionic neurons synapse </strong>with <strong>postganglionic neurons,</strong> the <strong>primary neurotransmitter</strong> is <strong>acetylcholine.</strong> The receptors present on the <strong>neurons in the ganglion</strong> that respond to <strong>acetylcholine are nicotinic cholinergic receptors,</strong> which are a<strong> type of cholinergic receptor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>receptors respond to acetylcholin</strong>e. Specifically, <strong>nicotinic cholinergic receptors</strong> are found in <strong>autonomic ganglia</strong> and mediate<strong> fast synaptic transmission </strong>between<strong> preganglionic and postganglionic neurons</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dopaminergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These receptors respond to <strong>dopamine </strong>and are <strong>not </strong>typically <strong>found in autonomic ganglia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Adrenergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These<strong> receptors respond to norepinephrine and epinephrine </strong>and are generally <strong>not found on neurons in the ganglia</strong>. They are typically<strong> located on the target organs </strong>innervated by <strong>postganglionic sympathetic neurons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Serotonergic</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>receptors </strong>respond to <strong>serotonin </strong>and are <strong>not </strong>present in the <strong>autonomic ganglia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All <strong>preganglionic fibres (Both sympathetic as well as parasympathetic) </strong>secrete<strong> Ach </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-ganglionic parasympathetic fibres </strong>secrete<strong> Ach </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Post-ganglionic sympathetic fibres </strong>secrete mostly<strong> noradrenaline.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 13220,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3314,
      "choices": [
        {
          "id": 13235,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebivolol</span></span></span></p>"
        },
        {
          "id": 13236,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sotalol</span></span></span></p>"
        },
        {
          "id": 13237,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betaxolol</span></span></span></p>"
        },
        {
          "id": 13238,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is beta</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> blocker with nitric oxide releasing property? &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>",
      "unique_key": "Q7545270",
      "question_audio": null,
      "question_video": null,
      "map_id": 35938,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Nebivolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nebivolol </strong>is a unique <strong>beta-blocker </strong>that possesses <strong>nitric oxide (NO) releasing properties</strong>. It acts as a <strong>selective beta-1 adrenergic</strong> <strong>receptor blocker </strong>and also <strong>promotes vasodilation </strong>by stimulating the <strong>release of nitric oxide</strong> from endothelial cells. This vasodilatory effect helps<strong> counteract the vasoconstrictive actions </strong>of traditional <strong>beta-blockers,</strong> contributing to its <strong>antihypertensive efficacy.</strong> <strong>Nebivolol </strong>is used in the <strong>management of hypertension and heart failure,</strong> and its<strong> NO-releasing property</strong> sets it <strong>apart from other beta-blockers </strong>in terms of its<strong> vasodilatory effects</strong> and potential advantages in certain patient populations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sotalol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Sotalol is a<strong> non-selective beta-blocker with Class III antiarrhythmic </strong>properties due to its <strong>inhibition of potassium</strong> <strong>channels in cardiac tissue</strong>. It does not have nitric oxide-releasing properties.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Betaxolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Betaxolol is a <strong>selective beta-1 adrenergic receptor blocker</strong> used primarily in the treatment of<strong> glaucoma and</strong> <strong>ocular hypertension.</strong> It <strong>does not </strong>possess <strong>nitric oxide-releasing properties.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Atenolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Atenolol is a <strong>selective beta-1 adrenergic receptor blocker</strong> commonly used in the management of <strong>hypertension</strong> <strong>and angina.</strong> It <strong>does not </strong>have<strong> nitric oxide-releasing properties.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nebivolol</strong> stands out among <strong>beta-blockers</strong> due to its unique <strong>nitric oxide-releasing property, </strong>which contributes to its<strong> vasodilatory</strong> <strong>effects and potential advantages </strong>in the treatment of <strong>hypertension and heart failure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers releasing nitric oxide (NO)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebuvilol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nipradilol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bopindolol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carteolol</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 13235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3323,
      "choices": [
        {
          "id": 13271,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alzheimer&rsquo;s disease</span></span></span></p>"
        },
        {
          "id": 13272,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parkinsonism</span></span></span></p>"
        },
        {
          "id": 13273,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain Barre syndrome</span></span></span></p>"
        },
        {
          "id": 13274,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To produce mydriasis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an indication of an anticholinesterase drug?</span></span></span></p>",
      "unique_key": "Q8406215",
      "question_audio": null,
      "question_video": null,
      "map_id": 35943,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Alzheimer&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterase drugs</strong> work by <strong>inhibiting the enzyme acetylcholinesterase,</strong> which<strong> breaks down acetylcholine,</strong> thus<strong> increasing its</strong> <strong>availability </strong>and action in the<strong> neural synapses</strong>. <strong>Alzheimer&rsquo;s disease</strong> is characterized by a <strong>deficiency of acetylcholine,</strong> and <strong>anticholinesterase drugs</strong> are used to <strong>mitigate this deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Parkinsonism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect</strong> because the <strong>primary neurotransmitter</strong> affected in<strong> Parkinsonism is dopamine, </strong>not acetylcholine. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Guillain Barre syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as this is an <strong>autoimmune condition</strong> affecting <strong>peripheral nerves</strong>, and <strong>anticholinesterase drugs </strong>are not the mainstay of treatment. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. To produce mydriasis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect</strong> because <strong>anticholinesterase drugs do not produce mydriasis</strong>; they are used to <strong>treat</strong> conditions like<strong> glaucoma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterase drugs </strong>are used in the treatment of <strong>Alzheimer&rsquo;s disease</strong> to<strong> increase the levels of acetylcholine</strong> in the <strong>brain,</strong> which helps in<strong> improving the cognitive symptoms </strong>of the<strong> disease.</strong></span></span></span></p>",
      "correct_choice_id": 13271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3331,
      "choices": [
        {
          "id": 13303,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They act by increasing the concentration of Ach by preventing its degradation </span></span></p>"
        },
        {
          "id": 13304,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reversible and irreversible anticholinesterases act by different mechanism of action </span></span></p>"
        },
        {
          "id": 13305,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticholinesterases act by binding to the anionic site of acetylcholinesterase </span></span></p>"
        },
        {
          "id": 13306,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All organophosphates anticholinesterases are water soluble</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding anticholinesterase?<strong> </strong></span></span></p>",
      "unique_key": "Q2140126",
      "question_audio": null,
      "question_video": null,
      "map_id": 35931,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) They act by increasing the concentration of Ach by preventing its degradation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterases</strong> inhibit the enzyme <strong>acetylcholinesterase, </strong>which is responsible for<strong> breaking down acetylcholine (ACh)</strong> in the <strong>synaptic cleft.</strong> By <strong>inhibiting this enzyme</strong>, <strong>anticholinesterases </strong>prevent the<strong> degradation of ACh</strong>, thus <strong>increasing its concentration</strong> and <strong>prolonging its action</strong> at the <strong>receptor sites.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Incorrect,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>reversible and irreversible anticholinesterases</strong> both <strong>inhibit acetylcholinesterase </strong>but <strong>differ </strong>mainly in the <strong>duration and strength of their binding </strong>to the enzyme. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Incorrect</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, while there is an<strong> anionic site on the enzyme, </strong>the action of <strong>anticholinesterases </strong>is primarily through binding to the <strong>esteratic site</strong>, where they <strong>prevent the hydrolysis of ACh.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Option D. Incorrect,</strong> <strong>not </strong>all <strong>organophosphates are water-soluble;</strong> some are<strong> highly lipid-soluble,</strong> which allows them to <strong>cross lipid</strong> <strong>membranes</strong>, including the <strong>blood-brain barrier.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anticholinesterase</strong> drugs work by <strong>inhibiting the enzyme</strong> that <strong>breaks down acetylcholine,</strong> leading to<strong> increased levels of ACh.</strong> This has various therapeutic applications, such as treating<strong> myasthenia gravis, reversing neuromuscular blockade, </strong>and as an<strong> antidote for</strong> <strong>anticholinergic poisoning.</strong> Their<strong> ability to cross membranes</strong> and enter the<strong> CNS </strong>or the <strong>eye </strong>varies based on their <strong>molecular structure.</strong></span></span></span></p>",
      "correct_choice_id": 13303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3335,
      "choices": [
        {
          "id": 13319,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
        },
        {
          "id": 13320,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ephedrine</span></span></span></p>"
        },
        {
          "id": 13321,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol</span></span></span></p>"
        },
        {
          "id": 13322,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is associated with tachyphylaxis? </span></span></span></p>",
      "unique_key": "Q1225505",
      "question_audio": null,
      "question_video": null,
      "map_id": 35933,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ephedrine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ephedrine </strong>is associated with <strong>tachyphylaxis,</strong> a phenomenon where <strong>repeated doses of a drug</strong> over a<strong> short period </strong>lead to a <strong>rapid</strong> <strong>decrease in the effect </strong>of that <strong>drug.</strong> <strong>Ephedrine, </strong>a <strong>sympathomimetic amine</strong>, stimulates <strong>both alpha and beta-adrenergic receptors,</strong> leading to<strong> increased heart rate, blood pressure, and bronchodilation.</strong> <strong>Tachyphylaxis</strong> to <strong>ephedrine </strong>occurs because its mechanism of action involves the <strong>indirect release of norepinephrine from nerve terminals,</strong> and with<strong> repeated use</strong>, the <strong>stores of norepinephrine</strong> can be <strong>depleted</strong>, leading to a<strong> diminished response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dopamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While dopamine can see a <strong>decrease in effectiveness over time,</strong> particularly in the context of <strong>long-term treatment</strong> for conditions like<strong> heart failure,</strong> it is <strong>not</strong> typically associated with <strong>rapid tachyphylaxis.</strong> <strong>Dopamine acts</strong> directly on<strong> dopamine receptors </strong>and<strong> indirectly on adrenergic receptor</strong>s to <strong>increase heart rate</strong> and <strong>blood pressure,</strong> among other effects.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Haloperidol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Haloperidol is an <strong>antipsychotic medication </strong>used to treat<strong> schizophrenia and acute psychosis</strong>. It works primarily by <strong>blocking dopamine receptors in the brain</strong>. <strong>Tachyphylaxis</strong> is <strong>not</strong> commonly associated with <strong>haloperidol or other antipsychotic medications.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Propranolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Propranolol is a <strong>beta-blocker </strong>used to manage<strong> hypertension, angina,</strong> and other conditions. It works by <strong>blocking beta-adrenergic receptors</strong>, <strong>reducing heart rate and blood pressure.</strong> T<strong>achyphylaxis</strong> is<strong> not </strong>a common issue with <strong>propranolol </strong>or most<strong> other beta-blockers.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> goal </strong>is to <strong>enhance</strong> understanding of<strong> pharmacodynamics,</strong> specifically the <strong>concept of tachyphylaxis, </strong>and to <strong>recognize which drugs</strong> are associated with this<strong> phenomenon.</strong> </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Examples of<strong> drugs acting </strong>by displacement include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyramine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ephedrine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudoephedrine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphetamines</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 13320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}